title: Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.
abstract: BACKGROUND
  Today, no objective criteria exist to differentiate between individual primary tumors and intra- or intermammary dissemination respectively, in patients diagnosed with two or more synchronous breast cancers. To elucidate whether these tumors most likely arise through clonal expansion, or whether they represent individual primary tumors is of tumor biological interest and may have clinical implications. In this respect, high resolution genomic profiling may provide a more reliable approach than conventional histopathological and tumor biological factors.
  
  
  METHODS
  32 K tiling microarray-based comparative genomic hybridization (aCGH) was used to explore the genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs, and was compared with histopathological and tumor biological parameters.
  
  
  RESULTS
  Based on global copy number profiles and unsupervised hierarchical clustering, five of ten (p = 1.9 x 10-5) unilateral tumor pairs displayed similar genomic profiles within the pair, while only one of eight bilateral tumor pairs (p = 0.29) displayed pair-wise genomic similarities. DNA index, histological type and presence of vessel invasion correlated with the genomic analyses.
  
  
  CONCLUSIONS
  Synchronous unilateral tumor pairs are often genomically similar, while synchronous bilateral tumors most often represent individual primary tumors. However, two independent unilateral primary tumors can develop synchronously and contralateral tumor spread can occur. The presence of an intraductal component is not informative when establishing the independence of two tumors, while vessel invasion, the presence of which was found in clustering tumor pairs but not in tumor pairs that did not cluster together, supports the clustering outcome. Our data suggest that genomically similar unilateral tumor pairs may represent a more aggressive disease that requires the addition of more severe treatment modalities, and underscores the importance of evaluating the clonality of multiple tumors for optimal patient management. In summary, our findings demonstrate the importance of evaluating the properties of both tumors in order to determine the most optimal patient management.
authors.affiliation: Division of Oncology, Department of Clinical Sciences, Lund University, SE-221 85 Lund, Sweden. Sara.Brommesson@med.lu.se
authors.forename: Sara
authors.initials: S
authors.lastname: Brommesson
authors.forename: Göran
authors.initials: G
authors.lastname: Jönsson
authors.forename: Carina
authors.initials: C
authors.lastname: Strand
authors.forename: Dorthe
authors.initials: D
authors.lastname: Grabau
authors.forename: Per
authors.initials: P
authors.lastname: Malmström
authors.forename: Markus
authors.initials: M
authors.lastname: Ringnér
authors.forename: Mårten
authors.initials: M
authors.lastname: Fernö
authors.forename: Ingrid
authors.initials: I
authors.lastname: Hedenfalk